Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
March 17, 2020 02:02 ET
|
BioNTech SE
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection Collaboration aims to accelerate global development of BNT162, leveraging expertise and...
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
March 16, 2020 02:00 ET
|
BioNTech SE
Announces BNT162 vaccine program for the prevention of COVID-19 infectionAnticipates start of clinical testing for vaccine in late April 2020 Plans to assemble a global consortium of partners to...
BioNTech berichtet über rapide Fortschritte bei COVID-19-Impfstoff-Programm zur Bekämpfung der globalen Gesundheitsbedrohung
March 16, 2020 02:00 ET
|
BioNTech SE
BNT162-Impfstoffprogramm zur Prävention von COVID-19-Infektionen angekündigtBeginn der klinischen Studie im April 2020 erwartetPläne für ein globales Konsortium an Kollaborationspartnern im Kampf...
BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
March 16, 2020 02:00 ET
|
BioNTech SE
BioNTech and Fosun Pharma will jointly conduct clinical trials of BNT162 in China, leveraging BioNTech’s proprietary mRNA vaccine technology and Fosun Pharma’s clinical development and...
BioNTech und Fosun Pharma arbeiten gemeinsam an der Entwicklung eines mRNA-basierten COVID-19-Impfstoffes in China
March 16, 2020 02:00 ET
|
BioNTech SE
BioNTech und Fosun Pharma werden gemeinsam klinische Studien für den Produktkandidaten BNT162 in China durchführen. Grundlage dafür bildet BioNTechs firmeneigene mRNA-Technologie sowie Fosuns...
BioNTech Announces Commencement of Public Offering of American Depositary Shares
February 03, 2020 16:46 ET
|
BioNTech SE
MAINZ, Germany, Feb. 03, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today, that it has filed a registration statement on Form F-1 with the United...
BioNTech plant öffentliches Angebot von American Depository Shares
February 03, 2020 16:46 ET
|
BioNTech SE
MAINZ, Deutschland, Feb. 03, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) hat heute die Registrierungsdokumente (Form F-1) bei der amerikanischen...
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
January 16, 2020 07:30 ET
|
BioNTech SE; Neon Therapeutics, Inc.
Further expands BioNTech’s growing CAR-T and TCR therapy pipeline through addition of neoantigen specific cell therapies, including a T cell therapy targeting shared RAS oncogenesAccelerates...
BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion
January 13, 2020 07:45 ET
|
BioNTech SE
MAINZ, Germany, Jan. 13, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ: BNTX, “BioNTech” or “the Company”), announced today that the Supervisory Board has appointed Ryan Richardson to the Management...
BioNTech stärkt globale Wachstumsstrategie und beruft Ryan Richardson als Chief Strategy Officer in den Vorstand
January 13, 2020 07:45 ET
|
BioNTech SE
MAINZ, Deutschland, Jan. 13, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ: BNTX, „BioNTech“ oder „das Unternehmen“) gab heute bekannt, dass der Aufsichtsrat Ryan Richardson als Chief Strategy...